Current treatments for the cardiorenal complications of diabetes are based on the control of blood glucose levels, mainly with metformin and sulfonylureas in type 2 diabetes mellitus and insulin mainly in type 1 diabetes [12]. This evidence concerns the gene INS and diabetes mellitus.